Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 643-650

  Schwartzbaum, Judith ^a,b   Jonsson, Fredrik ^b   Ahlbom, Anders ^b   Preston Martin, Susan ^c   Malmer, Beatrice ^d   Lönn, Stefan ^b   Söderberg, Karin ^b   Feychting, Maria ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EPILEPSY; FEMALE; GLIOBLASTOMA; GLIOMA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MENINGITIS; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; STROKE; SWEDEN; VIRUS ENCEPHALITIS;

ADULT; AGE OF ONSET; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; DIABETES MELLITUS; EPILEPSY; FEMALE; GLIOMA; HOSPITALIZATION; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 16844378683     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0119     Document Type: Article

References (27)

1. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155-60.
2. Olsen JH, Boice JD Jr, Jensen JP, Fraumeni JF Jr. Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 1989;81:803-8.
3. Lamminpaa A, Pukkala E, Teppo L, Neuvonen PJ. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol 2002;58:137-41.
4. Shirts SB, Annegers JF, Hauser WA, Kurland LT. Cancer incidence in a cohort of patients with seizure disorders. J Natl Cancer Inst 1986;77: 83-7.
5. Inskip PD. Etiology of brain tumors in adults. Epidemiol Rev 1995;17: 382-414.
6. Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106:423-8.
7. Aronson SM, Aronson BE. Central nervous system in diabetes mellitus. Lowered frequency in certain intracranial malignancies. Arch Neurol 1965;12:390-8.
8. Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
9. Mills PK, Preston-Martin S, Annegers JF. Risk factors for tumors of the brain and cranial meninges in Seventh Day Adventists. Neuroepidemiology 1989;8:266-75.
10. Cicuttini FM, Hurley SF, Forbes A. Association of adult glioma with medical conditions, family, and reproductive history. Int J Cancer 1997;71:203-7.
11. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
12. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer 1992;69: 2541-7.
13. Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K. Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 2001;154:161-5.
14. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncol 2002;4:278-99.
15. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609-15.
16. Lonn S, Klaeboe L, Hall P, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer 2004;108:450-5.
17. Rothman K, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998.
18. Benin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y. Primary brain tumors in adults. Lancet 2003;361:323-31.
19. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.
20. Nilsson A, Spetz C, Carsjo K, Nightingale R, Smedby B. Reliability of the hospital registry. The diagnostic data are better than their reputation. Lakartidningen 1994;91:603-5.
21. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors from survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-84.
22. Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 1998;34:98-102.
23. Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer 2004;100:2622-6.
24. Schaller B, Ruegg B. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 2003;44:1223-32.
25. Landy HJ, Lee TT, Potter P, Feun L, Markoe A. Early MRI findings in high grade glioma. J Neurooncol 2000;47:65-72.
26. Morgenstern L, Frankowski R. Brain tumor masquerading as stroke. J Neurooncol 1999;44:47-52.
27. Sawaya R, Ramo OJ. Systemic and thromboembolic effects of meningiomas. In: Al-Mefty O, editor. Meningiomas. New York: Raven Press, Ltd.; 1991. p. 137-44.